TELA Bio, Inc. (TELA) Financials

TELA Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 59.7 million 75.6 million
March 31, 2026 69.9 million 75.1 million
Dec. 31, 2025 81.4 million 75.1 million
Sept. 30, 2025 61.6 million 60.0 million

TELA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -9.4 million 613000
March 31, 2026 -11.3 million 816000
Dec. 31, 2025 -5.0 million 812000
Sept. 30, 2025 -5.9 million 955000

TELA Net Income

No data available :(

TELA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 30.4 million 56.1 million -
March 31, 2026 39.5 million 55.9 million 527000
Dec. 31, 2025 50.8 million 55.7 million 524000
Sept. 30, 2025 29.7 million 41.5 million 521000

TELA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 57.4 million
March 31, 2026 57.3 million
Dec. 31, 2025 51.7 million
Sept. 30, 2025 45.4 million

TELA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 59000 2.7 million 20.5 million 16.4 million
March 31, 2026 119000 2.3 million 20.7 million 16.5 million
Dec. 31, 2025 91000 2.1 million 18.3 million 14.5 million
Sept. 30, 2025 211000 2.3 million 19.2 million 15.2 million

TELA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 19.3 million 5.3 million
March 31, 2026 19.1 million 6.5 million
Dec. 31, 2025 20.9 million 7.1 million
Sept. 30, 2025 20.7 million 6.7 million

TELA

Price: $1.05

52 week price:
0.50
1.60

Earnings Per Share: -0.77 USD

Exchange: NGM

Sector: Healthcare

Industry: Medical Devices

Country: United States

Volume: 32300

Market Capitalization: 51.0 million

Links: